跳至主要内容
临床试验/ISRCTN30537186
ISRCTN30537186已完成不适用

A pilot study for the VITAL trial (Vitamins and Aspirin for the Treatment of Dementia)

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 0 人开始时间: 2004年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Male and female patients of all ages with a clinical diagnosis of dementia (according to Diagnostic and Statistical Manual of Mental Disorders, Fourth edition [DSM IV] criteria) of mild to moderate severity will be eligible to participate.
  • Concomitant therapy prescribed to affect cognitive function (e.g. Donepezil etc.) will be permitted provided the participant has been taking it for at least 3 months before the screening visit and intends to continue taking it for the duration of the VITAL treatment period.

排除标准

  • Not provided at time of registration

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

相似试验